A. Forgione

464 total citations
16 papers, 282 citations indexed

About

A. Forgione is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A. Forgione has authored 16 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in A. Forgione's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (2 papers). A. Forgione is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (2 papers). A. Forgione collaborates with scholars based in Italy, United States and South Korea. A. Forgione's co-authors include Fabio Piscaglia, Alessandro Granito, Francesco Tovoli, Matteo Renzulli, Matteo Bonini, Omar S. Usmani, Francesca Pignataro, Sara Marinelli, Francesca Benevento and Vito Sansone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Pharmacological Research.

In The Last Decade

A. Forgione

16 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Forgione Italy	7	110	76	65	58	53	16	282
S. Crespi Italy	8	229 2.1×	133 1.8×	43 0.7×	79 1.4×	35 0.7×	16	358
Clémence Hollande France	8	69 0.6×	31 0.4×	18 0.3×	93 1.6×	99 1.9×	20	355
S. Cattan France	6	124 1.1×	44 0.6×	31 0.5×	215 3.7×	137 2.6×	17	425
Arighno Das United States	11	71 0.6×	100 1.3×	22 0.3×	75 1.3×	75 1.4×	26	368
J. Wohlschläger Germany	10	50 0.5×	121 1.6×	24 0.4×	23 0.4×	24 0.5×	23	284
TS Yang Taiwan	5	32 0.3×	151 2.0×	90 1.4×	16 0.3×	22 0.4×	6	351
Muhammad Ashar Ali United States	9	20 0.2×	21 0.3×	46 0.7×	48 0.8×	73 1.4×	41	298
Enno Rodegerdts Germany	10	36 0.3×	25 0.3×	33 0.5×	16 0.3×	28 0.5×	15	306
Peter J. Altshuler United States	11	45 0.4×	30 0.4×	11 0.2×	42 0.7×	18 0.3×	27	287

Countries citing papers authored by A. Forgione

Since Specialization

Citations

This map shows the geographic impact of A. Forgione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Forgione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Forgione more than expected).

Fields of papers citing papers by A. Forgione

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Forgione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Forgione. The network helps show where A. Forgione may publish in the future.

Co-authorship network of co-authors of A. Forgione

This figure shows the co-authorship network connecting the top 25 collaborators of A. Forgione. A scholar is included among the top collaborators of A. Forgione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Forgione. A. Forgione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Terzi, Eleonora, Massimo Iavarone, Simona Leoni, et al.. (2022). Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5). Cancers. 14(2). 336–336. 11 indexed citations

Dong, Yi, Wen‐Ping Wang, Won Jae Lee, et al.. (2022). Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. Ultrasound in Medicine & Biology. 48(9). 1797–1805. 21 indexed citations

Granito, Alessandro, A. Forgione, Sara Marinelli, et al.. (2021). Experience with regorafenib in the treatment of hepatocellular carcinoma. Therapeutic Advances in Gastroenterology. 14. 1088199935–1088199935. 100 indexed citations

Granito, Alessandro, Sara Marinelli, A. Forgione, et al.. (2021). Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC. Journal of Hepatocellular Carcinoma. Volume 8. 477–492. 26 indexed citations

Forgione, A., Francesco Tovoli, Matteo Ravaioli, et al.. (2021). Contrast-Enhanced Ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features. SHILAP Revista de lepidopterología. 12(1). 1–9. 11 indexed citations

Tovoli, Francesco, Ingrid Garajová, Massimo Iavarone, et al.. (2021). Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: Implications for second-line trials. Digestive and Liver Disease. 53. S19–S19. 1 indexed citations

Ielasi, Luca, et al.. (2021). An update on atezolizumab for hepatocellular carcinoma. Drugs of today. 57(6). 365–365. 1 indexed citations

Rimini, Margherita, Sara Lonardi, Gianluca Masi, et al.. (2021). Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib. Hepatology Research. 51(7). 796–802. 5 indexed citations

Mulazzani, Lorenzo, A. Forgione, Eleonora Terzi, et al.. (2021). Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: A pilot study of a novel parameter aiming to improve the detection of wash-out. Digestive and Liver Disease. 53. S34–S34. 1 indexed citations

10.

Forgione, A., Francesco Tovoli, Matteo Ravaioli, et al.. (2020). Contrast ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features. 1 indexed citations

11.

Pignataro, Francesca, et al.. (2017). Asthma and gender: The female lung. Pharmacological Research. 119. 384–390. 84 indexed citations

12.

Miele, Luca, Stefania Boccia, C. Cefalo, et al.. (2007). [736] GENETIC AND ENVIRONMENTAL FACTORS RESPONSIBLE FOR OXIDATIVE STRESS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 46. S277–S277. 1 indexed citations

13.

Miele, Luca, Antonio Grieco, Alessandro Armuzzi, et al.. (2003). Nonalcoholic-steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation. Journal of Hepatology. 38. 197–197. 3 indexed citations

14.

Costanzo, Margherita Di, Luca Miele, Paola Di Rocco, et al.. (2002). Serum markers of fibrosis in nonalcoholic steatohepatitis (NASH). Digestive and Liver Disease. 34(9). 687–687. 2 indexed citations

15.

Miele, Luca, Antonio Grieco, Alessandro Armuzzi, et al.. (2001). C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy. Journal of Hepatology. 34. 198–198. 1 indexed citations

16.

Donelli, M.G., Tina Colombo, A. Forgione, & Silvio Garattini. (1972). Distribution of 6-Mercaptopurine in Tumor-Bearing Animals. Pharmacology. 8(4-6). 311–320. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact